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Detection of Regional Perfusion Abnormalities
During Adenosine Stress Echocardiography Using
Intravenous Perfluoropropane-enhanced Sonicated
Dextrose Albumin
Alan Kricsfeld, Thomas Porter, Karen Kilzer, Ubeydullah Deligonul, Feng Xie.
University of Nebraska Medical Center. Omaha, Nebraska
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Altering sonicated dextrose albumin microbubble gas diffusivity and solubil-
ity with perfluoropropane results in microbubbles which produce myocar-
dial contrast (MC) following an intravenous injection. It is unknown whether
the intensity of MC produced will accurately identify flow abnormalities due
to coronary ischemia. Accordingly, we measured peak myocardial videoin-
tensity (PMVI) from the left anterior descending (LAD) and left circumflex
(LCX) perfusion beds following intravenous 0.06 mllkg injections of perfluo-
ropropane enhanced sonicated dextrose albumin (PESDA). The same injec-
tion was given under resting conditions, and during peak adenosine stress
(ADS) (140)L/kg/min) in 6 open-chest dogs who had either no stenosis or
an angiographically significant stenosis in the proximal LCX coronary artery
(using quantitative angiography). PM VI from the LCX perfusion beds during
ADS was compared with actual flows measured with a Transonic Doppler
cuff around the LCX, and quantitative angiographic lOA) severity. Wall thick-
ening (WT) responses were also measured as the difference in LCX perfusion
bed end-diastolic and end-systolic wall thickness.
Injections of PESDA were given during 10 different stenosis severities in
the six dogs (range 0-87% diameter). There was a strong correlation be-
tween PMVI in the LCX bed and actual LCX flow by Doppler (r ~ 0.75, P
< 0.001). In the absence of a >50% stenosis, the PVI ratio in the LCX per-
fusion bed during ADS compared to baseline PVI ranged from 1.8 to 2.1,
while the Doppler flow ratios in the LCX ranged from 2.0 to 4.2. When a
greater than 70% diameter stenosis was present in the LCX, the PVI ratio
during ADS compared to baseline ranged from 0.8 to 1.4 IP = 0.02; com-
pared to PVI ratio without>70% stenosis), while the simultaneous Doppler
ratios also decreased to a range of 0.5 to 2.8. There was a close correlation
between Doppler flow ratios in the LCX and PMVI ratios during ADS (r ~
0.75; P < 0.05). WT increased during ADS by 20% or greater in three of the
six dogs despite a greater than 70% diameter stenosis. These data indicate
that the background-subtracted PMVI produced with intravenous PESDA can
identify abnormalities in coronary perfusion during ADS. This ultrasound con-
trast agent, therefore, could be a non-invasive method of determining my-
ocardial perfusion abnormalities during adenosine stress echocardiography
in humans.
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Non invasive myocardial contrast echocardiography requires an ultrasound
imaging mode capable of detecting small amounts of a crossing lungs con-
trast agent (CAl which reach the cardiac muscle. At present, commercial
B-Mode imaging can not visualize CA in myocardium after intravenous injec-
tion and transpulmonary passage. Second harmonic Mode imaging (SHM)
uses resonance properties of microbubbles to produce a gray scale image
of CA. We tested an prototype ultrasound machine (Acuson) using SHM to
detect CA SHU 508-A (Schering AG, Berlin) flow in an in vitro model at var-
ious concentrations, For each CA injection, videointensity in arbitrary Units
(VU), in SHM and B-Mode was assessed;
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We hypothesized that coronary stenoses, which are not flow-limiting at rest,
can be detected and the degree and spatial extent of blood flow mismatch
can be quantified during pharmacologically-induced coronary hyperemia us-
ing FS-069, a new intravenous contrast agent.
In 15 open-chest dogs, myocardial contrast echo (MCE) was performed
using 1-2 ml of FS-069 injected intravenously and myocardial blood flow
(MBF) was measured using radiolabeled microspheres at baseline and dur-
ing dipyridamole (0.56 mglkg) induced coronary hyperemia. In the presence
of this drug, a stenosis was placed either on the left anterior descending
(LAD) (n = 9) or the left circumflex (LC) (n = 6) coronary arteries and MCE
and MBF assessment were repeated at each stage. MCE images, where
contrast disparity between LAD and LC beds was maximal, were digitally-
subtracted from pre-contrast images and mean videointensities in the LAD
and LC beds were measured.
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Detection of Coronary Stenoses and Quantification
of Blood Flow Mismatch Using Myocardial Contrast
Echocardiography During Coronary Hyperemia with
FS-069, a New Intravenous Contrast Agent
Jane Somerville, Susan Stone. Grown-Up Congenital Heart Unit, Royal Brompton
Hospital, London, England
The possibility of transplantation for patients with pulmonary hypertension
makes it important to predict prognosis and causes of death. This studies
the state (Ability Index [AI]), complications, age at and cause of death of
143 patients with Eisenmenger Syndrome (E Group) due to VSD (28%), one
ventricle 19%1, A-V canal (8%) and truncus (8%), 50 of whom died during ob-
servation and 19 patients whose defects (VSD, duct, truncus) were repaired
in childhood and who died from progressive pulmonary hypertension (PPH
Group). In E Group, 8 deaths occurred before age 16 years (child in UK); only
3 "natural" deaths, the other 5 early in relation to cardiac surgery. 42 of E
Group died age 19-57 years, the majority in the 3rd decade from right heart
failure (24%), sudden (26%1, cerebral (14%1, haemoptysis 114%1, post car-
diothoracic intervention (14%), and extracardiac surgery 17%).22124%) of
93 alive in E Group survived to age 40-58 years with AI 2 (well, 13) and 3/4
(9). The PPH Group died age 2-35 years, 75% before 20 years. Prognosis
in the PPH Group is worse than Eisenmengers where death in childhood is
uncommon. In both groups frank heart failure and exertional presyncope are
bad prognostic features but commoner in the PPH Group. In Eisenmengers,
any surgery is dangerous. Large haemoptysis heralded disaster in 50% with
symptoms when due to right pulmonary artery thrombosis. With the better
prognosis of Eisenmenger cf. PPH, it is important to recognize those whose
pulmonary vascular resistance may rise after surgery and will thus have an
added risk for lung transplantation.
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There was a good correlation between the LAD/LC bed videointensity ra-
tio and LAD/LC bed MBF ratio (y = 0.2x + 0.71, r = 0.77, P = 0.0001, SEE
= 0.16, n = 45). In addition, the region showing hypoperfusion during LAD
or LC stenosis was planimetered and expressed as a percent of the myocar-
dial area in the short-axis slice. There was also a fair correlation between the
hypoperfused bed size on MCE and the hypoperfused myocardium as de-
termined by radiolabeled microspheres during LAD or LC stenosis (y = 0.8x
+ 3.3, r = 0.65, P < 0.001, SEE = 4.2, n = 151.
We conclude that it is possible to detect coronary stenoses that are not
flow limiting at rest with MCE using intravenous injection of FS-069 during
pharmacologically-induced coronary vasodilation. The magnitude of blood
flow mismatch and the spatial extent of relative hypoperfusion can also be
quantified using this approach. Thus it is possible not only to detect the pres-
ence of coronary stenoses, but also to quantify their severity and the quan-
tum of myocardium they supply using MCE from venous injection of 1-2 ml
of this new contrast agent.
SHU 508-A VU VU VU
injected volume (ml) B-Mode SHM % increase
0125 19 32 68
0.25 31 51 67
05 53 69 30
10 69 87 26
2.0 82 102 24
40 100 115 15
SHM vs. B-Mode p < 0.0001
Conclusions: SHM is more sensitive than B-mode in detecting SHU 508-A,
particularly at lower CA concentrations. SHM has a potential for the evalua-
tion of low CA concentration in clinical setting and therefore in myocardial
perfusion studies after CA intravenous injection.
